Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Loehrer, Franziska [VerfasserIn]   i
 Tschöpl, Martin [VerfasserIn]   i
 Angst, Christian Peter [VerfasserIn]   i
 Litynski, Piotr [VerfasserIn]   i
 Jäger, Kurt [VerfasserIn]   i
 Fowler, Brian [VerfasserIn]   i
 Haefeli, Walter E. [VerfasserIn]   i
Titel:Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease
Verf.angabe:Franziska M. T Loehrer, Martin Tschöpl, Christian P Angst, Piotr Litynski, Kurt Jäger, Brian Fowler, Walter E Haefeli
Jahr:2001
Umfang:8 S.
Teil:volume:154
 year:2001
 number:1
 pages:147-154
 extent:8
Fussnoten:Online 21 December 2000 ; Gesehen am 27.05.2021
Titel Quelle:Enthalten in: Atherosclerosis
Ort Quelle:Amsterdam [u.a.] : Elsevier Science, 1970
Jahr Quelle:2001
Band/Heft Quelle:154(2001), 1, Seite 147-154
ISSN Quelle:1879-1484
Abstract:Altered homocysteine metabolism associated with peripheral arterial occlusive disease (PAOD) may lead to impairment of vital methylation reactions through accumulation of S-adenosylhomocysteine (AdoHcy) as well as through alteration of the ratio S-adenosylmethionine (AdoMet)/AdoHcy. We determined AdoMet, AdoHcy, their ratio, and homocysteine in plasma as well as AdoMet, AdoHcy, and their ratio in erythrocytes of 61 patients with PAOD (age 49-93) and 50 healthy controls (age 41-87). Geometric mean values of plasma homocysteine, AdoMet, and AdoHcy were significantly increased in patients compared with controls (15.5 vs. 10.4 μmol/l**; 107 vs. 52.3* nmol/l; 55.0 vs. 23.1** nmol/l, respectively; *P<0.01, **P<0.001), while the ratio of AdoMet/AdoHcy was decreased in patients (1.92 vs. 2.52*). In erythrocytes patients exhibited increased levels of AdoHcy compared with controls (309 vs. 205 nmol/l**) whereas AdoMet (3351 vs. 3732 nmol/l*) and the ratio of AdoMet/AdoHcy (11.8 vs. 19.1**) were decreased. The odds ratio (OR) for developing PAOD with decreased AdoMet/AdoHcy ratio after adjustment for kidney function was significant for erythrocyte levels ≤14.2 (OR, 7.1 (6.9-7.2, 95% CI). In addition, hematocrit levels were found to be significantly decreased in patients versus controls (0.35 vs. 0.42 l/l**) and were significantly correlated with the ratio of AdoMet/AdoHcy in erythrocytes of the patients. Since the ratio of AdoMet/AdoHcy is closely linked with the activity of numerous enzymatic methylation reactions, these results suggest that methylation may be impaired in these patients.
DOI:doi:10.1016/S0021-9150(00)00449-4
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.1016/S0021-9150(00)00449-4
 Volltext: https://www.sciencedirect.com/science/article/pii/S0021915000004494
 DOI: https://doi.org/10.1016/S0021-9150(00)00449-4
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:-Adenosylhomocysteine
 -Adenosylmethionine
 Erythrocytes
 High performance liquid chromatography
 Homocysteine
 Methylation
 Peripheral arterial occlusive disease
K10plus-PPN:1759027219
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68741512   QR-Code
zum Seitenanfang